Skip to Main Content

Paper Details

Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions and monocytes for optimal therapeutic protection.
bioRxiv
26
2020
COVID-19, Fc, Human, SARS, SARS-, SARS-CoV, SARS-CoV-2, hamsters, human, inflammation, lung disease, mAbs, mice, monocytes

Datasets